Inventor · disambiguated record
Maxwell Sehested
Also filed as: SEHESTED MAXWELL
5 granted patents·7 pending applications·2 citations·filing 1997–2019
64Inventor score
Top patents by PatentIndex Score
12 records- 0166US10799469B2Combination therapies using HDAC inhibitorsTOPOTARGET UK LTD·Filed 2019·Granted Oct 13, 2020·0 cites·2 claims
- 0265US10285959B2Combination therapies using HDAC inhibitorsTOPOTARGET UK LTD·Filed 2014·Granted May 14, 2019·0 cites·1 claims
- 0358US2008213399A1Combination Therapies Using Hdac InhibitorsTOPOTARGET UK LTD·Filed 2006·Application pending·0 cites
- 0458US2014031539A16-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapyBIOCODEX INC·Filed 2013·Application pending·0 cites
- 0556US2019085017A16-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapyCLINIGEN GROUP PLC·Filed 2018·Application pending·0 cites
- 0655US2017145046A16-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapyCLINIGEN GROUP PLC·Filed 2016·Application pending·0 cites
- 0753US2009209535A16-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapyTOPOTARGET AS·Filed 2006·Application pending·0 cites
- 0838US2011003777A1Methods of Treatment Employing Prolonged Continuous Infusion of BelinostatTOPOTARGET AS·Filed 2009·Application pending·0 cites
- 0935US7906515B2Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiationTOPOTARGET AS·Filed 2005·Granted Mar 15, 2011·0 cites·3 claims
- 1032US2012270900A1Novel method of treatmentOLESEN UFFE·Filed 2010·Application pending·0 cites
- 1128US6727253B2Treatment of accidental extravasation of anthracyclinesANTIANTHRA APS·Filed 2001·Granted Apr 27, 2004·0 cites·31 claims
- 1220US6265385B1Topoisomerase II poison and bis-dioxopiperazine derivative combination therapyTOPO TARGET APS·Filed 1997·Granted Jul 24, 2001·2 cites·54 claims
Join the waitlist — get patent alerts
Get an alert when Maxwell Sehested files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →